Susan Lynch, PhD, ASM Distinguished Lecturer
Dr. Lynch is an Associate Professor of Medicine at the University of California, San Francisco, where she also directs the Microbiome Research Core and acts as Associate Director of the Microbiome in Inflammatory Disease Program. Her research program focuses primarily on the gastrointestinal microbiome and its role in established chronic inflammatory diseases, including airway diseases. She is extensively published with over 100 peer-reviewed publications, and holds six patents. Dr. Lynch has been awarded the Rebecca Buckley Lectureship by the American Academy of Allergy, Asthma and Immunology, was featured in International Innovation: Women in Healthcare, and was named one of Foreign Policy magazine’s “Global Thinkers” in 2016. She serves on the National Academy of Science Committee on Advancing Understanding of the Implications of Environmental-Chemical Interactions with the Human Microbiomes, and has recently founded Siolta Therapeutics, which develops next-generation microbiome therapeutics.